Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
POSITIVE PHYSICIANS HOLDINGS,INC. (PPHI)
|
|
| Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 | Sep-30-18 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 5.8 | 3.5 | 7.1 | 7.6 | 6.3 | 7.0 | 6.0 | 6.2 |
| Revenue growth | -6.8% | -50.0% | 18.5% | 23.6% | 3.3% | 8.9% | | |
| Loss and loss adjustment expenses | 3.2 | 3.2 | 3.9 | 4.1 | 4.3 | 3.3 | 7.8 | 3.8 |
| Policy acquisition costs | 0.6 | 1.3 | 1.5 | 2.2 | 2.0 | 2.1 | 2.0 | 2.2 |
| Other underwriting costs | 2.4 | 2.3 | 2.9 | 3.5 | 2.8 | 3.5 | 3.4 | 3.0 |
| Investment expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other operating expenses | -0.6 | -1.3 | -1.6 | -2.3 | -2.0 | -2.2 | -2.1 | -2.2 |
| EBITDA | 0.7 | -1.7 | 0.7 | 0.8 | -0.4 | 0.2 | -5.2 | -0.6 |
| EBITDA margin | 11.3% | -47.8% | 10.2% | 10.3% | -6.6% | 2.3% | -87.3% | -9.4% |
| Depreciation | 0.4 | 0.4 | 0.4 | 0.7 | 0.4 | 0.0 | 0.0 | 0.0 |
| EBIT | 0.3 | -2.0 | 0.4 | 0.1 | -0.8 | 0.1 | -5.2 | -0.6 |
| EBIT margin | 5.0% | -58.5% | 5.0% | 0.7% | -12.5% | 2.1% | -87.5% | -9.6% |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | 0.3 | -2.0 | 0.4 | 0.1 | -0.8 | 0.1 | -5.2 | -0.6 |
| Income taxes | -0.1 | -0.9 | 0.1 | 0.1 | -0.2 | 0.1 | -1.5 | -0.1 |
| Tax rate | | 44.9% | 32.8% | 109.1% | 28.5% | 37.9% | 28.2% | 20.4% |
| Net income | 0.4 | -1.1 | 0.2 | 0.0 | -0.6 | 0.1 | -3.8 | -0.5 |
| Net margin | 6.1% | -32.2% | 3.3% | -0.1% | -8.9% | 1.3% | -62.8% | -7.7% |
| |
| Basic EPS | $0.10 | ($0.31) | ($3,360,642.86) | | ($0.16) | $0.03 | | |
| Diluted EPS | $0.10 | ($0.31) | ($3,360,642.86) | | ($0.16) | $0.03 | | |
| |
| Shares outstanding (basic) | 3.6 | 3.6 | 0.0 | | 3.6 | 3.1 | | |
| Shares outstanding (diluted) | 3.6 | 3.6 | 0.0 | | 3.6 | 3.1 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|